These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8546857)

  • 21. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.
    Sixel-Döring F; Schweitzer M; Mollenhauer B; Trenkwalder C
    Sleep Med; 2009 Apr; 10(4):407-15. PubMed ID: 18945638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
    Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome.
    Matsumoto H; Ohminami S; Goto J; Tsuji S
    Arch Neurol; 2008 Jun; 65(6):827-9. PubMed ID: 18541806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive supranuclear palsy.
    Esper CD; Weiner WJ; Factor SA
    Rev Neurol Dis; 2007; 4(4):209-16. PubMed ID: 18195676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive disturbances in progressive supranuclear palsy.
    Litvan I
    J Neural Transm Suppl; 1994; 42():69-78. PubMed ID: 7964698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic.
    Yatabe Y; Hashimoto M; Kaneda K; Honda K; Ogawa Y; Yuuki S; Matsuzaki S; Tuyuguchi A; Kashiwagi H; Ikeda M
    Psychogeriatrics; 2011 Mar; 11(1):54-9. PubMed ID: 21447110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuropsychological evaluation can contribute to the diagnosis of movement disorders].
    Dubois B; Beato R; Villalpando JM
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S50-6. PubMed ID: 12773888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EEG findings in early-stage corticobasal degeneration and progressive supranuclear palsy: a retrospective study and literature review.
    Tashiro K; Ogata K; Goto Y; Taniwaki T; Okayama A; Kira J; Tobimatsu S
    Clin Neurophysiol; 2006 Oct; 117(10):2236-42. PubMed ID: 16920021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual event-related potentials in progressive supranuclear palsy.
    Nakano Y; Kaseda Y; Nakamura S; Neshige R
    Hiroshima J Med Sci; 2000 Mar; 49(1):37-42. PubMed ID: 10824455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of swallowing function in Parkinson's disease and progressive supranuclear palsy.
    Johnston BT; Castell JA; Stumacher S; Colcher A; Gideon RM; Li Q; Castell DO
    Mov Disord; 1997 May; 12(3):322-7. PubMed ID: 9159726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
    Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
    Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Descriptive study of a serie of patients affected by progressive supranuclear palsy].
    Villanueva-Haba VE; Garcés M; de Vera A; Valero C; Burguera JA
    Rev Neurol; 2001 Jun 1-15; 32(11):1027-30. PubMed ID: 11562823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors.
    Papapetropoulos S; Gonzalez J; Mash DC
    Eur Neurol; 2005; 54(1):1-9. PubMed ID: 16015014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between histopathological features of progressive supranuclear palsy and disease duration.
    Josephs KA; Mandrekar JN; Dickson DW
    Parkinsonism Relat Disord; 2006 Mar; 12(2):109-12. PubMed ID: 16337422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Ashour R; Jankovic J
    Mov Disord; 2006 Nov; 21(11):1856-63. PubMed ID: 16941460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinergic systems in progressive supranuclear palsy.
    Warren NM; Piggott MA; Perry EK; Burn DJ
    Brain; 2005 Feb; 128(Pt 2):239-49. PubMed ID: 15649952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distal-proximal differences in limb apraxia in corticobasal degeneration but not progressive supranuclear palsy.
    Soliveri P; Piacentini S; Paridi D; Testa D; Carella F; Girotti F
    Neurol Sci; 2003 Oct; 24(3):213-4. PubMed ID: 14598093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.